HC Wainwright restated their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report report published on Wednesday,Benzinga reports. The firm currently has a $12.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback